Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for Prevention of Contrast Induced Nephropathy in Diabetic Patients
NCT01364402Phase 3Unknown
- Sponsor
- Galilee Medical Center
- Start
- Aug 2011
- Primary completion
- Aug 2013
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin beta in contrast-induced nephropathy (CIN), sponsored by Galilee Medical Center. Status: unknown.
02
Drugs
epoetin beta
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT01364402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01364402.